Coherus BioSciences Inc. | Cash Flow
Fiscal year is February-January. All values USD Thousands.
2008
2009
2010
2011
2012
Net Income before Extraordinaries
84,325.00
197,475.00
77,962.00
53,982.00
2,017.00
Depreciation, Depletion & Amortization
97,249.00
95,219.00
77,922.00
70,108.00
58,199.00
Other Funds
97,502.00
0.00
7,334.00
0.00
1,885.00
Funds from Operations
119,725.00
6,625.00
127,895.00
49,190.00
69,727.00
Changes in Working Capital
40,120.00
42,941.00
13,684.00
43,892.00
23,474.00
Net Operating Cash Flow
159,845.00
49,566.00
114,211.00
5,298.00
93,201.00
Capital Expenditures
137,709.00
55,800.00
22,650.00
35,778.00
34,932.00
Sale of Fixed Assets & Businesses
0.00
4,813.00
54,428.00
1,248.00
7,739.00
Purchase/Sale of Investments
62,330.00
7,224.00
6,340.00
200.00
0.00
Net Investing Cash Flow
210,629.00
1,776.00
43,181.00
30,225.00
28,229.00
Cash Dividends Paid - Total
0.00
0.00
0.00
0.00
0.00
Issuance/Reduction of Debt, Net
264,502.00
8,622.00
57,721.00
44,525.00
11,350.00
Net Financing Cash Flow
31,212.00
19,425.00
64,571.00
44,171.00
13,847.00
Net Change in Cash
81,996.00
31,917.00
92,821.00
69,098.00
51,125.00
Free Cash Flow
22,136.00
6,234.00
91,561.00
30,480.00
58,269.00
Deferred Taxes & Investment Tax Credit
4,933.00
13,719.00
4,031.00
1,527.00
3,643.00
Net Assets from Acquisitions
0.00
0.00
0.00
0.00
0.00
Other Sources
912.00
45,539.00
5,063.00
4,105.00
0.00
Change in Capital Stock
198,212.00
10,803.00
484.00
354.00
612.00
Other Uses
11,502.00
0.00
0.00
0.00
1,036.00
Miscellaneous Funds
0.00
0.00
0.00
0.00
0.00
Extraordinaries
0.00
0.00
0.00
0.00
0.00
About Coherus BioSciences
View Profile
